Rivaroxaban contraindications: Difference between revisions

Revision as of 16:29, 3 March 2014

Rivaroxaban
XARELTO^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Rivaroxaban
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

XARELTO is contraindicated in patients with:

severe hypersensitivity reaction to XARELTO (e.g., anaphylactic reactions) [see Adverse Reactions (6.2)] ^[1]

Adapted from the FDA Package Insert.

@@ Line 7: / Line 7: @@
 XARELTO is contraindicated in patients with:
-*active pathological bleeding [see Warnings and Precautions (5.2)]
+*active pathological bleeding [see [[Rivaroxaban warnings and precautions |Warnings and Precautions]] (5.2)]
-*severe hypersensitivity reaction to XARELTO (e.g., anaphylactic reactions) [see Adverse Reactions (6.2)] <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = XARELTO (RIVAROXABAN) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] |url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10db92f9-2300-4a80-836b-673e1ae91610 | publisher =  | date =  | accessdate = }}</ref>
+*severe hypersensitivity reaction to XARELTO (e.g., anaphylactic reactions) [see [[Rivaroxaban adverse reactions |Adverse Reactions]] (6.2)] <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = XARELTO (RIVAROXABAN) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] |url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10db92f9-2300-4a80-836b-673e1ae91610 | publisher =  | date =  | accessdate = }}</ref>
 ==References==